Clinical
Clinical trial expertise
Prioritize leaders who have successfully navigated pipeline requirements, endpoints, site performance, and safety considerations.
- DSMB + safety board cadence
- Site + CRO health
- Biomarker + data readiness
Biotech & Pharma solutions
From discovery to delivery
Navigate the clinical and commercial pathway. We place scientific and operational leaders who manage regulatory hurdles and capital strategy for life sciences.
We prioritize leaders experienced with GxP environments and strict confidentiality requirements.
VTX-407Solid Tumor / Oncology
Phase II — Enrolling
Sites Active18
Enrolled247 / 300
Primary EndpointORR
PDUFA TargetQ2 2027
Enrollment Funnel
Screened
892
Eligible
614
Enrolled
247
Randomized
241
Completed
168
Key Personnel
PI:Dr. R. KeatingCRA:M. VasquezBiostat:S. Patel
DSMB: No Safety Signal
Clinical signals
Biotech & Pharmaceuticals market insights
Trial health, regulatory cadence, and launch scenarios surface for every biotech search.
Regulatory
Regulatory expertise
Identify leaders with proven experience managing FDA/EMA correspondence, inspection requirements, and manufacturing planning.
- Regulatory correspondence timelines
- CMC + quality milestones
- Inspection + audit readiness
Commercial
Commercial launch expertise
Evaluate candidates on their track record with AdCom preparation, payer engagement, and patient advocacy in commercial launches.
- Market access + HTA insights
- KOL + advocacy sentiment
- Launch sequencing + BD plans
Search teams
Clinician + operator bench
Connect with leaders holding MD/PhD, regulatory, and launch experience to pressure-test every mandate.
- Mechanism + indication review
- Agency + committee prep
- Launch + access integration
Translational Data
Biomarker Expression Panel
| Cohort A | Cohort B | Cohort C | Cohort D | |
|---|---|---|---|---|
| EGFR | ||||
| PD-L1 | ||||
| HER2 | ||||
| BRCA1 | ||||
| TP53 |
Response
72%
81%
64%
77%
Endpoint Met: PD-L1 Cohort B
Market research
Biotech market intelligence
Identify qualified candidates by researching trial milestones, regulatory updates, M&A activity, and leadership movements across biotech clusters.
- Clinical milestone trend awareness
- Regulatory and inspection requirement understanding
- Biotech hub talent identification
NDA on track — Q3 2027
Regulatory Intelligence
Filing & Milestone Tracker
IND Filing
100%
Dr. ChenPhase II Complete
80%
Clinical OpsNDA Submission
45%
Reg AffairsEMA Filing
30%
EU Reg LeadAdCom / PDUFAExec Team
Leadership alignment
Launch and scale expertise
Evaluate candidates on their experience with AdCom preparation, supply readiness, and payer engagement in commercial launches.
- AdCom and inspection preparation experience
- BD and partnership relationship management
- Market access and patient advocacy experience
Enrollment Analytics
Patient Flow Waterfall
Pre-screened1,240
Screened892
28% excluded
Eligible614
31% ineligible
Enrolled312
49% declined
Randomized298
4% withdrawn
Analyzed271
9% lost to follow-up
Enrollment Target: 85% met
Lifecycle coverage
Leader profiles that keep science, quality, and launch in sync
Clinical rigor desk
Candidates with MD/PhD backgrounds who have authored trial specs and evaluated study narratives.
- Endpoint + biomarker experience
- Site + CRO oversight experience
- Trial reliability mitigation experience
Regulatory air traffic control
Leaders who coordinate agency correspondence, quality, and manufacturing updates.
- Inspection readiness experience
- CMC timeline management
- Regulator Q&A experience
Launch + access leaders
Commercial + payer strategists who shape launch narratives.
- AdCom + payer prep experience
- Advocacy + KOL feedback experience
- BD + partnership sequencing
Search Methodology
From discovery through onboarding in four phases.
Clinical Landscape Mapping
Map therapeutic area talent, pipeline adjacencies, and regulatory experience to define the search mandate.
Targeted Outreach
Confidential engagement across pharma, biotech, and CRO networks with compensation and transition intelligence.
Scientific Vetting
Candidates evaluated for trial oversight, regulatory fluency, and alignment with the molecule's development stage.
Selection & Integration
Offer negotiation, board introductions, and structured 90-day check-ins with key stakeholders.
Connected solutions
Pair biotech mandates with Ventrix teams.
Enterprise teams guide pivotal programs while startup squads cover platform spinouts and venture-backed assets.
Search parameters can be tailored to align with clinical milestone requirements.
Biotech + pharma FAQs
Yes. We can run a confidential search process and share sensitive information only with essential team members and candidates.
We prioritize leaders with FDA, EMA, PMDA, and NMPA experience to tailor leadership profiles per jurisdiction.
We partner with scientific founders to align leadership requirements, ensuring candidates respect both scientific rigor and mission alignment.